JEFFREY GRECO: Open Payments
NPI 1770667388 · MT CARMEL, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,031 in 50 payments from 15 companies in 2025. Trend: 2023 $2,177 · 2024 $1,654 · 2025 $1,031
Food & beverage: $1,031
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $206 |
| AstraZeneca Pharmaceuticals LP | 5 | $194 |
| Lilly USA, LLC | 4 | $93 |
| GlaxoSmithKline, LLC. | 4 | $90 |
| Amgen Inc. | 5 | $90 |
| Esperion Therapeutics, Inc. | 4 | $73 |
| PFIZER INC. | 4 | $67 |
| Exact Sciences Corporation | 3 | $51 |
| Corcept Therapeutics | 2 | $36 |
| Novo Nordisk Inc | 2 | $31 |
Products named: JARDIANCE, BREZTRI, ELIQUIS, REPATHA, NEXLETOL, TRELEGY ELLIPTA, MOUNJARO, FARXIGA.
Industry payments across PA — which companies pay providers there.
